PTC Non Recurring from 2010 to 2026
| PTCT Stock | USD 69.45 1.25 1.77% |
Non Recurring | First Reported 2004-12-31 | Previous Quarter 33.4 M | Current Value 217.8 M | Quarterly Volatility 38.2 M |
Check PTC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PTC Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 201.6 M, Total Revenue of 974.2 M or Research Development of 645.4 M, as well as many indicators such as Price To Sales Ratio of 4.7, Dividend Yield of 0.0 or Days Sales Outstanding of 52.14. PTC financial statements analysis is a perfect complement when working with PTC Therapeutics Valuation or Volatility modules.
PTC | Non Recurring | Build AI portfolio with PTC Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PTC Stock Analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.